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ihis review is a sequel to our 4 previous reports highlighting
he most important literature regarding single-photon emis-
ion computed tomography (SPECT) myocardial perfusion
maging, cardiac positron emission tomography (PET),
ardiac computed tomography (CT), and cardiac magnetic
esonance imaging (MRI). This report primarily covers the
nglish-language literature between July 1, 2008, and June
0, 2009. It also includes selected papers from JACC:
ardiovascular Imaging between January 1, 2008, and June
0, 2008, which we overlooked in last year’s review, as the
ournal was not yet listed in Index Medicus. The continued
rowth in cardiac imaging literature, exemplified by the
rrival of both Circulation: Cardiovascular Imaging and
ACC: Cardiovascular Imaging, has continued to challenge
s in reaching decisions as to which articles merit inclusion
n this review. We recognize that our decisions will inevi-
ably please some authors and disappoint others. We can
ssure everyone that we have made every effort to be as
bjective as possible in reaching these ever more difficult
ecisions. We believe that an integrated, multimodality
maging approach is optimal for the solution of clinical
roblems, which is reflected in the organization of this
ummary around topical themes, and in the preference that
e have given to studies that take a multimodality approach.
echnical Advances
PECT. Advances in gamma camera technology have
ade more rapid SPECT imaging feasible. Berman et al.
1) reported on their initial experience imaging 374 patients
ith a high-speed SPECT system and a rapid dual-isotope
maging protocol that was completed in 30 min. Overall
mage quality was good to excellent, even though rest
maging was begun within 2 min of technetium injection.
ET. The use of PET for the assessment of perfusion has
een limited by the requirement for a cyclotron or a
ubidium generator. Sherif et al. (2) reported excellent tracer
ptake and image quality with a new fluorine-18–labeled
ET perfusion agent, BMS 747158-02, an analog of the
rom the *Division of Cardiovascular Diseases and Internal Medicine, Department of
edicine, and †Department of Radiology, Mayo Clinic and Mayo Foundation,
ochester, Minnesota. Dr. Gibbons has received research grant support from King
harmaceuticals and served as a consultant to Molecular Insight Pharmaceuticals. Dr.
raoz has served as a consultant for Medtronic.p
Manuscript received September 6, 2009; revised manuscript received September 25,
009, accepted September 28, 2009.nsecticide pyridaben, in a rat model of myocardial infarc-
ion (MI). The accompanying paper by Camici and Rimoldi
3) clarified the potential importance of this early work.
ET and CT. There has been an increasing interest in
therosclerosis imaging using PET FDG. Rudd et al. (4)
eported on subjects who underwent vascular PET imaging
long with CT. There was little overlap between plaque
nflammation assessed by PET and calcification assessed by
T, suggesting that calcification may represent the late
tage of “burnt-out” atherosclerosis. Wykrzykowska et al.
5) found both coronary artery and aortic FDG uptake in
atients with malignancy who underwent PET-CT after a
ow carbohydrate–high fat diet and reported a weak corre-
ation between FDG coronary uptake and angiographic
isease.
T. A new 128-row dual-source CT scanner made its
ebut at the Radiological Society of North America meeting
n November 2008. This new scanner allows for very
igh-pitch spiral CT scanning of the heart, which decreases
xposure time, allowing “single-beat” imaging of the coro-
ary arteries. Initial reports of this technology describe very
ow radiation doses, approximately 1 to 2 mSv for coronary
omputed tomography angiography (CTA) (6,7).
Early reports also describe another “high-definition” CT
canner that employs a novel detector material and a
ifferent reconstruction algorithm as compared with con-
entional systems. This scanner promises increased spatial
esolution and decreased image noise, both of which have
een shown to improve visualization of coronary artery
tents (8).
RI. Over the past year, 2 MRI techniques, which were
reviously noncardiac, were applied to the heart. Diffusion
ensor imaging (DTI) is an MRI technique to measure the
atural dispersal of water molecules in tissue. Because water
olecules preferentially diffuse along fibers, DTI has been
sed to image fiber tracts, primarily in the brain (9), but has
ad only limited use in in vivo clinical populations.
Wu et al. (10) used an in vivo cardiac DTI technique to
escribe changes in cardiac microstructure in 17 patients 3
eeks and 7 months after MI. Several measures of micro-
tructure integrity were acutely abnormal in myocardium
djacent to the infarct as compared with remote myocar-
ium. Late improvement in wall thickening correlated with
mprovement in mean diffusivity, one of the microstructure
arameters.
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Year in Cardiac Imaging February 2, 2010:483–95In magnetic resonance elastography, tissue is externally
ibrated, and MRI is used to directly image the waves
ropagating in tissue in order to measure stiffness. Increased
tiffness in the liver is associated with hepatic fibrosis (11).
n a pilot study on normal volunteers, Sack et al. (12)
stimated myocardial stiffness using in vivo cardiac magnetic
esonance elastography by vibrating the chest and measuring
he amplitude of the waves in the left ventricle.
iability
T. Cury et al. (13) evaluated cardiac CT in 102 patients
34 ST-segment elevation myocardial infarction [STEMI];
8 controls) and compared the results with SPECT. Over-
ll, detection of acute MI was very good (sensitivity  94%,
pecificity  97%), but correlation with SPECT infarct size
as only moderate (r 0.48, mean difference7 9%).
RI. The most established MRI technique for detecting
nfarcted myocardium is delayed enhancement imaging.
ecent studies have focused on delayed enhancement in the
cute phase, with emphasis on evaluating peri-infarct border
one areas and myocardium at risk.
Phrommintikul et al. (14) used an MRI method called
2-weighted imaging to measure myocardial edema and
dentify myocardium at risk. In 15 patients with acute MI,
he authors used MRI to define myocardium at risk as
dematous, noninfarcted myocardium. At 3-month follow-
p, there was a modest correlation between improved
ystolic wall thickening and myocardium at risk at baseline
r  0.42, p  0.01).
O’Regan et al. (15) described the relationship between
dematous and infarcted tissue in 15 patients after acute
TEMI. The lateral boundaries of edema closely approxi-
ated the region of delayed enhancement, (i.e., infarction)
Figure 1 Change in DE
In this patient with acute myocardial infarction, images at day 1 show transmural
marked decrease in DE at days 1 to 7 (arrows); at 1 year, there is recovery of fun
(16). MRI  magnetic resonance imaging.uggesting that cardioprotective strategies “may have limited
otential for improving myocardial salvage at these infarct
argins.”
However, Englblom et al. (16) questioned whether acute
elayed enhancement accurately represents infarct size or
verestimates it by including peri-infarct tissue. In 22
atients with acute MI, delayed enhancement was measured
t multiple time points over 1 year. The volume of enhanc-
ng myocardium decreased rapidly in the first week and
radually thereafter (Fig. 1). The authors suggested that the
nitial rapid decrease in delayed enhancement was due to
iable, peri-infarct tissue that was not infarcted.
Further studies are needed to define the optimal timing
nd best MRI technique(s) to distinguish infarcted tissue
rom viable, peri-infarct tissue. This distinction has impor-
ant implications for clinical treatment, and (hopefully)
atient outcomes.
T and MRI. MRI has better tissue characterization than
T, and CT delayed enhancement remains at a preliminary
tage compared with MRI. However, CT has much higher
patial resolution than MRI, a potential advantage for
uantifying areas of heterogeneous delayed enhancement at
he perimeter of infarcts, which might be a substrate for
rrhythmias (17). Schuleri et al. (18) compared 64-detector
T peri-infarct zone size with MRI peri-infarct size in 15
ini-pigs. Using pathology as a gold standard, MRI under-
stimated infarct size at very thin slice thickness (0.1 mm),
hereas CT did not, suggesting that CT may be useful in
uantifying the peri-infarct zone.
PECT and MRI. Carlsson et al. (19) compared MRI
dema imaging with SPECT for detection of myocardium
t risk in 16 patients with STEMI. Following established
ethodology, Tc-99m tetrofosmin was injected intrave-
d enhancement (DE) and akinesis of the anterior wall (arrows). There was a
espite the transmural DE at baseline (arrows). Modified from Englblom et al.delaye
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February 2, 2010:483–95 Year in Cardiac Imagingously before percutaneous coronary intervention (PCI),
nd SPECT images were acquired within hours after PCI.
n contrast, the MRI images were performed electively 1
eek after PCI (Fig. 2). SPECT and MRI measurements
orrelated well (r2  0.70) with little variation (mean
ifference in left ventricular [LV] mass 2.3  5.7%). The
uthors concluded that MRI provided similar information
o SPECT with less logistical difficulty.
atient Safety
PECT/CT/MRI. Fazel et al. (20) analyzed claims data
rom 952,420 nonelderly adults in 4 states, and reported
oderately elevated radiation doses in 19.4% of enrollees
nd high doses in 2.1%. SPECT MPI accounted for 22.1%
f the total effective dose.
T. The radiation dose associated with coronary CTA
emains a concern. Raff et al. (21) implemented available
ose-reduction strategies in a 15-hospital consortium in
ichigan and reduced estimated radiation doses in half
ithout a decrease in image quality (Fig. 3).
Hausleiter et al. (22) evaluated 1,965 cardiac CT scans
erformed at 50 international sites to determine radiation
xposure in routine clinical practice. Although the mean
adiation dose (12 mSv) was reasonable for retrospective
lectrocardiographic (ECG)-gated CT, there was signifi-
ant variation in radiation dose between sites with incon-
istent application of dose-reduction strategies.
As reported in last year’s paper, prospective ECG trig-
ering is gaining acceptance as a means of lowering radia-
ion doses for coronary CTA (Table 1) (23–29).
T and SPECT. Gerber et al. (30) issued a comprehen-
ive American Heart Association statement on ionizing
adiation that emphasized physician education, physician
Figure 2 Comparison of SPECT to MRI Images
Short-axis single-photon emission computed tomography (SPECT) images obtained
was injected before reperfusion. The defect in the inferior wall shows the myocard
show edema (T2-STIR) correlated with SPECT defect (r2  0.70, p  0.001). Dela
show irreversible infarction were much smaller. Reprinted, with permission, from Cudgment, and efforts to reduce patient dose whenever
easible.
T and PET. Hybrid PET–CT imaging has tremendous
otential. Javadi et al. (31) reported their initial experience
ith low-dose, prospectively gated coronary CTA, which
educed radiation exposure by 70% without compromising
mage quality or integration with PET.
RI. Although pacemakers and internal defibrillators have
ong been absolute contraindications to MRI examinations,
everal recent studies have suggested that some patients with
acemakers or defibrillators may be able to undergo MRI
canning. Mollerus et al. (32) reviewed 75 noncardiac MRI
cans in 40 patients and found no unanticipated device-
rogramming changes, no changes in battery status or
atient with ST-segment elevation myocardial infarction. The SPECT radiotracer
risk. Increased signal magnetic resonance imaging (MRI) images designed to
hancement cardiovascular magnetic resonance (DE-CMR) images designed to
n et al. (29).
Figure 3 Improvement in Radiation Dose
Distribution of patients by estimated radiation doses in 15 hospital imaging
centers in Michigan, before and after introduction of established dose-reduction
techniques. Reprinted, with permission, from Raff et al. (21).in a p
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Year in Cardiac Imaging February 2, 2010:483–95apture threshold, and no change in cardiac troponin-I or
yoglobin values. Pulver et al. (33) performed cardiac MRI
n 11 congenital heart disease patients with epicardial pacing
eads. No inappropriate pacing or arrhythmias occurred.
evice voltages, thresholds, and lead impedances were
imilar before and after MRI.
oronary Artery Disease (CAD): Diagnosis
PECT. The effect of caffeine on adenosine stress perfu-
ion is a long-standing concern.
Reyes et al. (34) studied the effects of caffeine ingestion (2
ups of coffee) on the magnitude of SPECT perfusion
bnormality induced by a standard adenosine dose of 140
g/kg/min, and a higher dose of 210 g/kg/min. Caffeine
ramatically reduced SPECT defect size after standard aden-
sine infusion, but not after high-dose infusion (Fig. 4). The
Figure 4 Effect of Caffeine on Adenosine Response
Effect of caffeine ingestion on the summed difference score (SDS) by single-
photon emission computed tomography perfusion imaging. Individual values,
mean, and 95% confidence intervals are shown for (A) standard adenosine
infusion (140 g/kg/min) and (B) high-dose adenosine (210 g/kg/min).
Reprinted, with permission, from Reyes et al. (34).
tudies on 64-Slice Scanners Comparing Radiation Dose foretrospective Gat d CT and Prospect ve Triggered CT Radiation DoTable 1 Studies on 64-Slice Scanners Comparing Radiation DoRetrospective Gated CT and Prospective Triggered CT
Authors (Ref. #) Population Retro/Pro, n Scan
Shuman et al. (23) ED patients 42/32 SSC
Blankstein et al. (24) Referred for cardiac CT
(coronary and noncoronary)
188/42 DS
Gopal et al. (25) Suspected CAD 34/12 SSC
Klass et al. (26) Suspected CAD and heart rate
65 beats/min
20/20 SSC
Alkadhi et al. (27) Suspected CAD 50/40 DS
Husmann et al. (28) Suspected or known CAD 100/100 SSC
Hirai et al. (29) Suspected CAD and heart rate
75 beats/min
34/28 SSC
AD  coronary artery disease; CT  computed tomography; DSCT  dual-source computed t
etrospective gated; SNR  signal-to-noise ratio; SSCT  single-source computed tomography.cuthors suggested that patients should be screened carefully
or caffeine ingestion prior to adenosine SPECT, and
electively considered for high-dose adenosine infusion.
Regadenoson is a novel adenosine agonist approved for
harmacologic stress testing. Using the data from 2 multi-
enter phase 3 trials, Cerqueira et al. (35) reported that
egadenoson was equivalent to adenosine in diagnostic
fficacy, and better tolerated from a symptomatic stand-
oint. In an accompanying editorial, Udelson (36) provided
mportant insights from the development programs of the
ew adenosine agonists.
The dosage used for technetium perfusion agents varies
cross countries. Notghi et al. (37) reported that the activity
njected for 2-day protocols needed to be increased above
he usual 400 MBq (10.8 mCi) in the United Kingdom for
ll patients above 80 kg.
PECT–CT. The potential value of combined SPECT
nd coronary CTA has yet to be fully explored. Husmann
t al. (28) reported that coronary CTA provided additional
nformation regarding pre-clinical atherosclerosis in 38 of
5 patients (45%) studied with prospectively gated coronary
TA and stress-only SPECT.
T. Ruzsics et al. (38) describe a new method utilizing
imultaneous dual-energy cardiac CT to identify cardiac
schemia by determining myocardial iodine content. This
ethod accurately detected myocardial ischemia compared
ith SPECT (sensitivity  91%, specificity  92%) and
greed closely with catheterization for the detection of
tenosis (sensitivity  98%, specificity  88% per segment)
Fig. 5).
George et al. (39) evaluated adenosine stress perfusion
T as an adjunct to coronary CTA in 40 patients with
PECT perfusion defects. They found good sensitivity and
pecificity for the detection of obstructive CAD (86% and
2%, respectively) and promising initial results regarding
uantification of perfusion abnormalities; however, only 2 of
reversible defects seen on SPECT were appropriately
r
ation Dose
Radiation Dose, mSv
Image QualityRetro Pro
31.8 5.1 9.2 2.2 Higher quality with prospective trigger (p  0.05)
13.4 7.8 3.2 1.6 No difference; increased noise with prospective
trigger (p  0.0002), but no difference in SNR
11.3 3.4 1.9 0.8 No difference
18.9 3.8 3.7 0.8 No difference
9.0 1.0 1.3 0.3 No difference
19.7 4.2 2.2 0.7 No significant difference in sensitivity or specificity
for detecting 50% at catheter angiography
20.0 3.5 4.1 1.8 No difference
phy; ED  emergency department; mSv  millisievert; Pro  prospective triggered; Retro sese fo
Radi
ner
T
CT
T
T
CT
T
Tharacterized using CT perfusion.
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487JACC Vol. 55, No. 5, 2010 Gibbons et al.
February 2, 2010:483–95 Year in Cardiac ImagingMeijboom et al. (40) compared coronary CTA to
nvasive angiography with measurement of fractional flow
eserve. They found a moderate correlation between
TA and invasive angiography for the severity of stenosis
r  0.53; p  0.0001), but limited agreement between
oth modalities and fractional flow reserve (kappa 0.25
or both), suggesting that anatomical imaging may not
rovide a complete assessment of coronary disease.
Several important multicenter trials comparing 64-row
oronary CTA with cardiac catheterization were published
his year. In the Core 64 trial, Miller et al. (41) studied 291
atients from 9 centers located in 7 different countries; 56%
f the patients had significant CAD. Although they re-
orted a sensitivity of 85% (95% confidence interval [CI]:
9% to 90%) and specificity of 90% (95% CI: 83% to 94%)
n a per-patient basis, the negative predictive value was a
isappointing 83%, and the authors concluded that “multi-
etector CT angiography cannot replace conventional
Figure 5 Dual-Energy CT Images and SPECT
Invasive angiography (A) and coronary computed tomography (CT) (B) demon-
strates culprit lesion (arrow) in the first diagonal branch. Dual-energy CT
images performed using 140 and 80 kV (C and D) are used to generate a
myocardial iodine map (E), which shows a perfusion deficit (arrows) corre-
sponding to findings from single-photon emission computed tomography (F,
arrows). Reprinted, with permission, from Ruzsics et al. (38).oronary angiography at present.” In contrast, in the dCCURACY (Assessment by Coronary Computed To-
ographic Angiography of Individuals Undergoing Invasive
oronary Angiography) trial, Budoff et al. (42) prospec-
ively analyzed 230 subjects from 16 different sites with a
ower prevalence of 14% of significant CAD (70% stenosis).
he authors found an overall sensitivity and specificity of
4% and 83% for the detection of 70% stenosis, with a
igher negative predictive value of 99%, reflecting the lower
revalence of CAD in their population.
Meijboom et al. (43) evaluated coronary CTA in 360
ymptomatic patients from 3 university hospitals (disease
revalence  68%) and found excellent overall sensitivity of
9% with preserved negative predictive value (97%); how-
ver, specificity was relatively low because CTA overesti-
ated the severity of stenosis.
In the NIMISCAD (Non Invasive Multicenter Italian
tudy for Coronary Artery Disease) trial, Marano et al. (44)
nrolled 367 patients from 20 sites in Italy (prevalence of
AD  56%) and found consistently high negative predic-
ive values of coronary CTA performed on 16-row (91%;
 264) and 64-row (89%; n  63) systems.
Along with these multicenter trials, several studies were
ublished comparing newer generations of CT scanner with
atheterization (Table 2) (6,45–50).
Quantitative stenosis analysis remains an issue for coro-
ary CTA. Dodd et al. (51) compared various CT post-
rocessing methods with quantitative coronary angiography
n 29 patients for the evaluation of nonculprit lesions.
lthough they found good correlation between the 2
odalities for vessels 3 mm in diameter (R  0.78 to
.91, p 0.01), the correlation was poor for calcified lesions
R  0.01 to 0.20), and 24% of segments with 30%
tenosis had to be excluded from analysis.
In the ROMICAT (Rule Out Myocardial Infarction
sing Computer Assisted Tomography) study, Hoffmann
t al. (52) evaluated CT scans in 368 patients with acute
hest pain and an inconclusive initial workup. The extent of
laque (area under the curve [AUC]  0.88) and presence
f stenosis (AUC  0.82) predicted acute coronary syn-
rome (ACS) independent of cardiovascular risk factors and
hrombolysis In Myocardial Infarction (TIMI) risk score
AUC  0.63). Fifty percent of patients had no evidence of
AD by CT, a finding that carried 100% sensitivity and
00% negative predictive value for ACS. However, stenosis
y CT had limited sensitivity for ACS (77%), and the study
ad no major adverse cardiac events at 6 months.
RI. Several previous studies have shown that MRI may
etect clinically unsuspected MIs in asymptomatic patients
ho are elderly or at risk. In a novel study of 102 male
arathon runners age 57  6 years, Breuckmann et al. (53)
ound that 12 (12%) of the runners had delayed enhance-
ent on MRI, compared with 4% of age-matched controls.
he number of marathons completed was an independent
redictor of the presence of delayed enhancement, suggest-
ng that the amount of exercise may have “had a role in the
evelopment” of delayed enhancement.
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PECT. The much-anticipated DIAD (Detection of
schemia in Asymptomatic Diabetics) study reported on the
se of adenosine stress SPECT imaging for CAD screening
n 1,123 participants with type II diabetes and no symptoms
f CAD (54). The cumulative cardiac event rates were low,
veraging 0.6% per year, and were not significantly reduced
y SPECT screening (Fig. 6), even though participants with
ormal SPECT or small SPECT defects had lower event
ates than those with moderate or large defects.
Cantor et al. (55) assessed the impact of mild-to-
oderate ischemia (assessed by either SPECT or echo) on
atients enrolled in the OAT (Occluded Artery Trial),
hich randomized stable patients with an occluded infarct-
elated artery to PCI or optimal medical treatment alone.
lthough patients who underwent stress testing had better
utcomes, mild-to-moderate ischemia was not associated
ith any difference in outcomes, and did not predict any
dvantage for PCI.
4-Detector Row Dual-Source Coronary CTA Compared With CatheTable 2 64-Detector Row Dual-Source Coronary CTA Compared
Authors (Ref. #) N* Rhythm Age, yrs
P
Une
Se
Achenbach et al. (6) 53: no HRC† NSR 61 11
47: HRC† NSR 63 13
Stolzmann et al. (45) 100 70 beats/min† 64 7
Piers et al. (46) 60 NSR 64 (57–70)‡
Rixe et al. (48) 76 NSR 65 10
Tsiflikas et al. (47) 44 NSR (19)/AF (25) 68 9
Tsiflikas et al. (49) 170 NSR 64 9
Meng et al. (50) 109 NSR 63 9
All patients were scheduled for clinically indicated coronary angiography. †Achenbach et al. (6) s
7 were randomized to receive beta-blocking medication for heart rate control (HRC) with a target
eta-blocker.
AF  atrial fibrillation; HR  heart rate; NS  not specified; NSR  normal sinus rhythm.
Figure 6 Effect of Screening on Clinical Outcomes
Cumulative incidence of cardiac death or nonfatal myocardial infarction for par-
ticipants in the DIAD (Detection of Ischemia in Asymptomatic Diabetics) study,
according to whether they were randomly assigned for systematic single-photon
emission computed tomography screening or not. Reprinted, with permission,
from Young et al. (54).aRenal failure has been increasingly recognized as an
dverse prognostic factor. Hakeem et al. (56) followed 652
atients for 2.15  0.8 years following stress SPECT and
ound that SPECT findings and renal dysfunction were
ndependent predictors of subsequent cardiac death. Even in
he presence of a normal scan, patients with chronic kidney
isease had a less benign prognosis (Fig. 7).
The accurate prediction of sudden cardiac death remains
clinical challenge. Piccini et al. (57) demonstrated a
ignificant association between summed stress score and
ubsequent sudden cardiac death in 6,383 patients with
AD followed over a median of 6.1 years. As Albert (58)
ointed out in an accompanying editorial, the clinical
ignificance of this finding is uncertain without analysis of
he impact of the results on risk stratification. Tamaki et
l. (59) reported that cardiac metaiodobenzylguanidine
MIBG) and washout rate and EF were independently
ignificant in predicting sudden cardiac death in 106 out-
atients with systolic heart failure, but the study was limited
y a small number of events (n  18) and the absence of
eta-blocker therapy.
PECT and CT. Prognostic comparisons of SPECT and
oronary CTA are of great current interest. van Werkhoven
t al. (60) followed 541 patients who underwent both
PECT and coronary CTA for a median of 672 days.
lthough SPECT and coronary CTA provided indepen-
ent prognostic information, the study was limited by a
elatively small number of hard events (16).
ET. Ejection fraction (EF) can be easily measured with
ated PET. Lertsburapa et al. (61) reported that EF by
ET provided prognostic information that was incremental
o PET stress perfusion, and suggested that EF should be
outinely measured.
Two important studies addressed the limited available
ata regarding the prognostic value of PET perfusion. Tio
t al. (62) followed 344 medically treated patients with
schemic heart disease, for a median of 7 years and reported
hat myocardial perfusion reserve assessed by dipyridamole-
giography for Detection of >50% StenosesCatheter Angiography for Detection of >50% Stenoses
le
s
Unevaluable
Segments Included
in Analysis?
Additional
Beta-Blocker
Premedication
HR (beats/min),
Mean  SD
Per Patient
Sensitivity/
Specificity
No No 69 14 95%/94%
No Yes 59 10 100%/85%
No Yes 61 5 100%/93%
No NS 63 12 100%/45%
No No§ 68 9 100%/83%
NS NS 69 14 81%/54%
N/A No 64 12 94%/79%
No No 71 13 98%/79%
00 patients: 53 were randomized to have no pre-scan medication for heart control (no HRC) and
te of 60 beats/min or less. ‡Age50 years excluded. §41% on daily beta-blocker; 71% on dailyter AnWith
ercent
valuab
gment
4%
3%
4%
7%
0.7%
5%
0%
2%
tudied 1
heart rammonia PET was highly predictive of cardiac death.
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February 2, 2010:483–95 Year in Cardiac Imagingorbala et al. (63) reported similar findings with vasodilator
tress rubidium PET on a much larger cohort of 1,432
atients followed for 1.7  0.7 years. They also reported
ncremental prognostic value for stress-induced EF changes
easured in a subset of 985 patients.
T. The presence of coronary calcium predicts cardiac
vents. This year, several studies reported the outcomes of
atients with negative or very low coronary calcium scores.
arwar et al. (64) performed a systematic review of 49
tudies of coronary calcium CT exams on 71,595 asymp-
omatic patients and 3,924 symptomatic patients. Over a
ean follow-up period of 50 months, 154 of 29,312
symptomatic patients with no coronary calcium had car-
iovascular events (0.47%), compared with 1,749 of 42,283
symptomatic patients with coronary calcium (4.14%; p 
.001). Among symptomatic patients, 17 of 921 patients
1.8%) without calcium had events over the ensuing 42
onths, compared with 270 of 3,003 (8.99%) with coronary
alcium. The cumulative relative risk ratio for the absence of
oronary calcium in asymptomatic patients was 0.15 (95%
I: 0.11 to 0.21; p  0.001) and in symptomatic patients
.09 (95% CI: 0.04 to 0.20; p  0.0001).
Blaha et al. (65) evaluated all-cause mortality in a cohort
f 44,052 patients over a 5-year period. In the 5,388 patients
ith low positive coronary artery calcium (CAC) scores
CAC  1 to 10), mortality was 1.06%, which was
ignificantly higher than in patients with no coronary
alcium (0.52%) and significantly lower than in patients
ith CAC 10 (3.96%).
There have been limited data on the prognostic value of
oronary CTA. Hadamitzky et al. (66) followed 1,256
atients with suspected CAD over a median of 18 months
nd reported that 50% stenosis in any coronary artery was
Figure 7 Effect of GFR on Clinical Outcomes
Annual rate of cardiac death according to summed stress score (SSS) by
single-photon emission computed tomography and estimated glomerular filtra-
tion rate (GFR). There were significant (p  0.05) differences across strata of
SSS and GFR. Reprinted, with permission, from Hakeem et al. (55). n  num-
ber of patients in each stratum.redictive of severe cardiac events (0.17% risk vs. 0.1% risk;dds ratio: 17.3; 95% CI: 3.6 to 82.5), and added to the
ramingham risk score (Fig. 8). The rate of severe cardiac
vents in the overall study group was only 0.8%.
Motoyama et al. (67) evaluated coronary CTA in 1,059
atients to determine plaque characteristics associated with
n unfavorable prognosis (mean follow-up: 27  10
onths). Twenty-two percent (10 of 45) of patients with
ow-attenuation coronary plaques and associated positive
emodeling developed an ACS compared with 0.49% (4 of
20) of patients with atherosclerotic plaques demonstrating
either of these features (hazard ratio: 22.8; p  0.001).
one of the 167 patients with normal coronary arteries
eveloped ACS.
Carrigan et al. (68) followed 277 patients for 2 years
mean 2.3  0.8 years). The presence of proximal coronary
laque (at least 30% diameter reduction) and total plaque
core each added significantly to clinical variables in pre-
icting major cardiac events.
Van Lingen et al. (69) followed 178 patients with no
ignificant coronary stenosis (50%) by CTA for 1 year
range 51 to 1,113 days) and found no unstable angina,
I, or death, although 2 patients did have coronary
evascularization.
RI. As MRI stress testing has become more established,
here is a growing body of literature supporting the prognostic
mportance of these examinations (Table 3, Fig. 9) (70–73).
Delayed enhancement alone has prognostic significance.
won et al. (74) followed 349 patients with ischemic
ardiomyopathy for 2.6  1.2 years; the amount of delayed
nhanced myocardium was associated with an increased risk
f all-cause mortality or cardiac transplantation, indepen-
ent of age or LV ejection fraction.
Figure 8 Prognostic Value of Coronary CTA
Rate of severe cardiac events according to the presence or absence of
obstructive coronary artery disease (CAD) detected by coronary computed
tomography angiography (CTA). Reprinted, with permission, from Hadamitzky
et al. (66). Pt  patients.
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Year in Cardiac Imaging February 2, 2010:483–95MRI can help guide cardiac resynchronization therapy
CRT). Bilchick et al. (75) performed MRI on 20 patients
rior to CRT; the combination of an MRI dyssynchrony
ndex with MRI infarct quantification produced 100%
ensitivity and 85% specificity for predicting CRT response.
tructure and Function
T. ECG-gated CT is increasingly being used for mor-
hologic assessment of extracoronary cardiac structures;
everal studies established normal reference values. Budoff
t al. (76) used electron beam CT and 64-row multidetector
T to measure LV mass in 2,238 patients without a known
ause of left ventricular hypertrophy (LVH) and found low
ariability of the CT measurements by both techniques. They
ound that application of existing echocardiographic criteria for
VH mass would misclassify a significant number of patients,
nd recommended new CT criteria for LVH.
Lin et al. (77) used CT in 103 patients to estimate normal
anges for LV, left atrial, right ventricular, and right atrial
ize, function, and mass.
rognostic Value of Stress MRI in Patients With Known or SuspectTable 3 Prognostic Value of Stress MRI in Patients With Know
Authors
(Ref. #) N Patient Population Stress Outcome
M
D
Dall’Armellina
et al. (70)
200 LVEF 55% rest WMA
subopt. echo
Dobutamine CD/MI
Doesch
et al. (71)
81 Intermed. stenosis Adenosine
first-pass
D/CVA/ACS
Wallace
et al. (72)
266 Women subopt. echo Dobutamine MI/CD
Bodi
et al. (73)
214 STEMI Dobutamine CD/MI 1
Adjusted for risk factors and prior infarction.
Abn  abnormal; ACS  acute coronary syndrome; CAD  coronary artery disease; CD  card
VEF  left ventricular ejection fraction; MI  myocardial infarction; MRI  magnetic resonance
uboptimal stress echocardiography; WMA  wall motion abnormality; other abbreviations as in
Figure 9 Prognostic Value of Dobutamine MRI
Patients with stress-induced wall motion abnormalities (an increase in wall
motion size index [WMSI]) at dobutamine magnetic resonance imaging (MRI)
were more likely to have myocardial infarction or cardiac death after 5 years of
follow-up. Modified from Dall’Armellina et al. (70).(Halpern et al. (78) compared CT planimetry of aortic
alve area with echocardiography in 41 patients and found
ood correlation (r 0.88) when direct measurement of LV
utflow tract area was used in the continuity equation in
lace of estimates based on diameter.
The use of CT for detection of atrial thrombus remains
n active topic for investigation. Feuchtner et al. (79)
ompared ECG-gated CTA with transesophageal echocar-
iogram (TEE) in 64 patients and found excellent sensitiv-
ty (100%) and decent specificity (73%) for left atrial
hrombus. Hur et al. (80) evaluated a 2-phase CT angio-
raphic technique in 55 stroke patients and found excellent
pecificity (98%) with preserved sensitivity (100%) for the
etection of left atrial appendage thrombus as compared
ith TEE. Martinez et al. (81) performed CT and TEE on
02 patients prior to ablation of atrial fibrillation. The
bsence of a filling defect on CT had a 100% negative
redictive value for LA thrombus.
RI. PLAQUE. MRI plaque characterization of the coro-
ary arteries is technically challenging due to their small size
nd rapid motion. However, plaque characterization is
asier in other vessels, such as the carotid artery. Boussel
t al. (82) reported a multicenter trial in which 108 patients
ith 50% carotid artery stenoses were imaged at baseline
nd 1 year later. Patients not taking a statin had an increase
n wall volume of 7.87  13.58%, which was significantly
reater than the increase in wall volume of 1.14  9.9% in
atients taking a statin (p  0.029).
Miao et al. (83) described coronary wall remodeling in
79 asymptomatic patients enrolled in the MESA (Multi-
thnic Study of Atherosclerosis). They imaged the proxi-
al coronary artery in cross-section and compared the total
oronary wall thickness with the outer contour area and the
uminal area, before and after adjustment for body mass
ndex and LV mass. The predominant change in vessel size
as due to a larger increase in outer wall area than in the
uminal area, which the authors interpreted as positive
emodeling (Figs. 10 and 11).
ORPHOLOGY. Several studies used MRI parameters to
redict outcome in nonischemic conditions. Bluemke et al.
ADSuspected CAD
llow-Up
n (yrs)
Abn
MRI (%) HE (%)
HE/Abn
MRI (%)
HE/Normal
MRI (%) HR Comment
30 17.5 27 14 1.7* Not predictive if
LVEF 40%
0.67 56 11.1 20 0 NC
1.6 27 9.4 33.3 7.5 4.1
–2.8) 26 4.7 11 2.5 NS
ath; CVA  cerebrovascular accident; D  death; HE  hard event; Intermed.  50%, 75%;
ng; NS  not significant; STEMI  ST-segment elevation myocardial infarction; subopt. echo 
.ed Cn or
ean Fo
uratio
5
2.5
6.2
.5 (0.8
iac de84) showed the prognostic value of LV mass by MRI in
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February 2, 2010:483–95 Year in Cardiac Imaging,098 asymptomatic volunteers followed for 4 years as part
f the MESA study. LV mass and LV mass divided by LV
olume were both associated with an increased risk of heart
ailure after adjustment for a variety of risk factors.
McGann et al. (85) used MRI to predict response to
adiofrequency pulmonary vein isolation for treatment of
trial fibrillation in 46 patients. Patients who responded to
adiofrequency ablation had more left atrial wall delayed
nhancement than patients who did not respond (19  7%
s. 12  6%, p  0.004).
Adabag et al. (86) showed that delayed enhancement had
rognostic value in 177 patients with hypertrophic cardio-
Figure 10 MRI Imaging of Coronary Artery Wall
Magnetic resonance imaging (MRI) cross-section through the left main coronary
artery (arrow, inset) shows eccentrically thickened arterial walls. Reprinted,
with permission, from Miao et al. (83).
Figure 11 Relationship of Coronary Lumen and Outer Contour
Comparison of coronary lumen area and coronary outer contour area to coronary w
correlated with the mean coronary wall thickness (r  0.62 and r  0.09, p  0.0
significantly greater than that of the lumen area increase (p  0.0001). Reprintedyopathy. Delayed enhancement was associated with a
reater likelihood of ventricular tachyarrhythmias.
Zagrosek et al. (87) described the patterns of reversible
nd irreversible injury in 36 patients with myocarditis who
ere imaged within the first week of presentation and again
t 18  10 months. The acute phase was characterized by
ncreased edema (increased signal on T2-weighted im-
ges), and irreversible injury was characterized by delayed
nhancement.
In contrast, Schietinger et al. (88) found delayed
nhancement in 19 of 24 (79%) of chronic hemodialysis
atients. Thirteen of the 19 (68%) patients with delayed
nhancement had a pattern suggestive of fibrosis, but not MI.
Steen et al. (89) found that 15 of 41 (37%) transplant
atients had delayed enhancement suggestive of infarction.
mong patients with only mild transplant coronary disease
y catheter angiography, 5 of 22 (23%) had delayed en-
ancement suggestive of infarction.
ealth Care Policy
PECT. Levin et al. (90) used the nationwide Medicare
dministrative database to examine the trends in myocardial
erfusion imaging between 1998 and 2006. The rate of
rivate office utilization per 1,000 Medicare beneficiaries
ncreased by 215% for cardiologists in office settings, com-
ared with only 32% among radiologists in hospital settings.
he 2006 utilization rate for cardiologists in office settings
as 47.3 per 1,000 Medicare beneficiaries, more than 4-fold
igher than the rate of 10.7 for stress echocardiograms.
Appropriateness criteria may help to moderate these
rowth rates. McCully et al. (91) compared the stress
PECT criteria and the stress echo criteria in 298 patients
ckness in women. The outer contour and the lumen area were both positively
d p  0.05, respectively), but the slope of the outer contour area increase was
permission, from Miao et al. (83).all thi
01 an
, with
w
c
t
r
i
o
i
r
U
i
R
r
a
p
i
S
p
i
a
S
a
r
p
c
S
n
s
a
w
o
c
c
i
g
t
C
C
p
w
f
p
v
1
a
c
t
t
c
a
C
A
e
m
c
R
M
s
R
1
1
1
1
1
1
1
492 Gibbons et al. JACC Vol. 55, No. 5, 2010
Year in Cardiac Imaging February 2, 2010:483–95ho underwent stress echocardiography. They reported
onsiderable differences in patient classification according to
he 2 different sets of criteria, suggesting the need for future
efinements. Hendel et al. (92) published the revised Amer-
can College of Cardiology Foundation (along with multiple
ther organizations) appropriateness criteria for SPECT
maging, which clarified many of the issues that had been
aised in studies of the original criteria published in 2005.
nfortunately, Bautista et al. (93) surveyed 126 physicians
n their institution and found that American College of
adiology appropriateness criteria were rarely used, and
anked well behind Google as a resource. Mehta et al. (94)
pplied the 2005 appropriateness criteria to their academic
ractice and reported that 13% of their SPECT studies were
nappropriate. Khandaker et al. (95) reported that stress
PECT studies could effectively risk stratify asymptomatic
atients at moderate CAD risk by Framingham criteria, an
ndication that was considered to be of uncertain appropri-
teness in the 2005 criteria.
PECT and CT. Will coronary CTA save money? Using
large administrative claims database, Min et al. (96)
eported lower total healthcare and CAD expenditures for
atients without known CAD who were evaluated with
oronary CTA compared with those who underwent
PECT, without any differences in outcome. Unfortu-
ately, important clinical information, such as pre-test
ymptoms, smoking status, and cholesterol levels, were not
vailable in the database.
In a second study, Min et al. (97) followed 8,235 patients
ithout known CAD for 1 year after either coronary CTA
r SPECT to determine subsequent events and medical
osts. Overall event rates were low (0.4%). Although total
osts were lower for CT patients (by $1,075 per patient), the
ncidence of revascularization was higher in the SPECT
roup, suggesting higher pre-test likelihood of disease in
hese patients.
T. Menon et al. (98) evaluated the utility of coronary
TA to prevent invasive coronary angiography after sus-
ected false positive stress testing. Only 57 of 385 patients
ho had multidetector CTA after stress testing were re-
erred on to cardiac catheterization (14.8%); CTA com-
ared well with invasive angiography (positive predictive
alue  94%, negative predictive value  100%). Although
1% of the CTAs were false positive (6/54), the use of CT
s a gatekeeper resulted in a theoretical 4-fold cost savings.
Using a Monte Carlo simulation model to evaluate
oronary CTA for triage of “low-risk” chest pain patients in
he emergency department, Ladapo et al. (99) demonstrated
heoretical cost savings in female patients and relatively
ost-effective care in male patients ($6,400 per quality-
djusted life-year) as compared with standard of care.
onclusions
s we have said previously, we hope that this review will
ncourage the reader to examine some of these papers inore detail and, ultimately, to more carefully apply the
orrect imaging modality to each clinical problem.
eprint requests and correspondence: Dr. Raymond J. Gibbons,
ayo Clinic, Gonda 5, 200 First Street, SW, Rochester, Minne-
ota 55905. E-mail: gibbons.raymond@mayo.edu.
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